Clinical trials: Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R)
- Condition Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R)
- Funder type Industry (pharma, biotech, devices)
Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R)
Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R)
The study aims to assess the feasibility/acceptability of real-world activity monitoring by the Syde® wearable device in PSP-R. The Syde® collected data will be compared to on-site conventional clinical endpoints, including…
- Trial name
- PROSPER-SYDE (NCT07389018)
- Where
- France
- Volunteers
- 30 people
- Sponsor
- SYSNAV